February 13, 2018European patent “NANOPARTICLE FORMULATION CONTAINING FARNESYLTHIOSALICYCLIC ACID”European patent application (WO2015167408)(PCT/TR2014/000248) entitled "NANOPARTICLE FORMULATION CONTAINING FARNESYLTHIOSALICYCLIC ACID" has been concluded positively and the registration decision has been finalized. Farnesylthiosalicylic acid (Salirasib, FT A), a new generation antineoplastic agent, is…
